Annular Cold Plasma Array for Deep Tissue Infection Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for deep tissue infections, such as those in orthopedic hardware, often require multiple surgeries and rely heavily on antibiotics, which may not effectively reach and eradicate infections, leading to recurring issues and potential amputation in severe cases.

Innovation Solution

An annular cold plasma device with multiple ports converging at a treatment area, powered by high voltage RF and gas supply, to enhance penetration and intensity of cold plasma for deep tissue treatment without surgical intervention.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple surgeries and systemic antibiotics are used to treat deep tissue infections, then the infection may be controlled, but the treatment requires repeated surgical procedures and antibiotics may not effectively reach the infection site

Engineering Contradiction:
Improveinfection eradication effectivenessVSAvoidtreatment procedure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The treatment is divided into two stages: first removing hardware and debriding tissue, then applying antibiotic-impregnated materials locally at the infection site. This segmentation allows targeted delivery of antibiotics directly where needed, improving effectiveness while reducing the need for repeated systemic treatments and surgeries.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Antibiotic-impregnated materials serve as an intermediary between the external antibiotic source and the deep tissue infection site. These materials are placed directly at the infection site after debridement, allowing sustained local release of antibiotics that can effectively reach and eradicate the infection without requiring repeated surgical interventions.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If hardware is removed and antibiotic materials are left in place for 6 weeks, then infection resolution is achieved, but the joint remains non-functional during this period

Engineering Contradiction:
Improveinfection resolutionVSAvoidjoint functionality loss
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The antibiotic-impregnated materials are prepared and positioned in advance during the first surgery, creating a controlled local antibiotic reservoir. This preliminary action ensures that effective antibiotic concentrations are maintained at the infection site from the beginning, potentially reducing the treatment duration and allowing earlier joint functionality restoration while still achieving complete infection resolution.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If cold plasma is applied to deep tissue infections, then non-invasive treatment is achieved, but plasma penetration depth to reach deep tissues is limited

Engineering Contradiction:
Improvetreatment invasivenessVSAvoidplasma penetration depth
Core Design Contradiction:
Ease of operationVSLength of stationary object

Solution Approach 1:

The patent transitions from surface-level plasma application to deep tissue treatment by introducing a gas delivery system that transports cold plasma through body cavities and conduits. This dimensional change allows the plasma to reach deep infection sites internally while maintaining the non-invasive nature of the treatment, effectively overcoming the penetration depth limitation.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for effective treatment of deep tissue infections and disorders by increasing plasma penetration and intensity, reducing the need for surgeries, minimizing complications, and providing a non-invasive solution for musculoskeletal pain and inflammation.

Implementation Method 1

receiving, from a cold plasma power supply, electrical energy at two or more cold plasma devices via one or more high voltage RF ports... receiving, from a gas source, gas at the two or more cold plasma devices via one or more gas supply ports... outputting cold plasma from the two or more cold plasma devices

Methodology Applied
Scientific EffectCold plasma generation: Plasma

Data Source

PatentUS9646808B2Cold plasma annular array methods and apparatus
Publication Date: 2017.05.09 PLASMOLOGY4 INC
  • US9646808B2 patent drawing
  • US9646808B2 patent drawing
  • US9646808B2 patent drawing

AI summary

Methods and apparatus are described that use an array of two or more cold plasma jet ports oriented to converge at a treatment area. The use of an array permits greater tissue penetration by cold plasma treatments. This approach enables treatment of deeper infections of soft and hard tissues without surgical intervention. For example, this approach can treat sub-integumental infections, such as those common to joint replacements, without surgically opening the issues overlying the deeper infection.